BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Influenza
,
Stem cell
,
Early pregnancy factor
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL-2
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Granulocyte-macrophage progenitor cell of bone marrow
Dendritic (plasmacytoid) cell
Skeletal muscle psoas
Plasma cell of spleen
Monocyte of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Cytomegalovirus infection
Legionella infection
Listeriosis
Hyperglycemia
Severe combined immunodeficiency disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
enterotoxin I, staphylococcal
Antigens, CD28
Antigens, CD3
Antigen-Antibody Complex
MSLN protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SATB1
IL2RB
FCER1G
CD247
CD247
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?
The contribution of interleukin-2 to effective wound healing.
Low-Dose IL-2 in the Treatment of Lupus.
Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3/GPR174.
Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Low-dose IL-2 in Established T1D - The "PROREG" Study
Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic M…
T1DM Immunotherapy Using Polyclonal Tregs + IL-2
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ